TrialChest2026

A Randomized, Placebo-Controlled, Double-Blind, Crossover Trial of Inhaled Nitric Oxide in Patients With Mild-to-Severe COPD.

Sophie É Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.